Skip to content

Reducing Behavioral and Psychological Symptoms of Dementia: Family Caregivers (Aim 1)

Reducing Behavioral and Psychological Symptoms of Dementia (BPSD) for Acutely-Ill Persons With Alzheimers Disease and Related Dementias Via Patient Engagement Specialists

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04481568
Enrollment
158
Registered
2020-07-22
Start date
2020-02-03
Completion date
2021-12-29
Last updated
2022-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease and Related Dementias

Keywords

Behavioral and Psychological Symptoms of Dementia, Alzheimer's Disease and Related Dementias, Hospitalization

Brief summary

Persons with Alzheimer's Disease and Related Dementias (ADRD) account for 3.2 million hospital admissions per year and have over three times more hospitalizations than those without cognitive impairment, yet hospital caregivers (HCGs) are ill-prepared to manage patients with ADRD with less than 5% reporting mandatory dementia care training. Three-quarters of hospitalized persons with ADRD display Behavioral and Psychological Symptoms of Dementia (BPSD) associated with functional and cognitive decline, increased resource consumption, institutionalization, premature death, and caregiver burden. The overall objective is to test the preliminary efficacy of an innovative model of care, PES-4-BPSD, for reducing BPSD by empowering Patient Engagement Specialists (PES) to deliver dementia care for acutely-ill patients with ADRD. Traditionally, mental health assistants with training in crisis-prevention techniques provide care to psychiatric patients. On the intervention unit, these mental health assistants, as PES, purposefully engage patients with BPSD. In the pilot study, investigators found patients with cognitive impairment admitted to the PES unit were significantly less likely to require constant observation, chemical and physical restraints, suggesting improved management of BPSD. The central hypothesis is that PES-4-BPSD will improve the ability of PES to create an enabling milieu that addresses factors leading to BPSD and improves the experience of hospital caregivers. Guided by a social-ecological framework, PES-4-BPSD incorporates dementia education and training, environmental modifications-cohorting, increased staffing-PES, and staff support. The investigators' multidisciplinary research team is well-positioned to accomplish the following: Aim 1) Determine the preliminary efficacy of PES-4-BPSD for reducing BPSD during hospitalization, and Aim 2) Evaluate whether dementia care training improves the perceived ability of PES staff (intervention) and nurse assistant staff (control) to care for hospitalized persons with ADRD. For Aim 1, investigators will conduct a non-randomized preliminary efficacy trial of the PES-4-BPSD intervention enrolling N=158 patients (79 control, 79 intervention). The primary outcome will be presence of BPSD during hospitalization using the Neuropsychiatric Inventory-Questionnaire (NPI-Q). In Aim 2, investigators will use survey methodology in a repeated measures design to evaluate within and between-group differences in attitudes, experience, and satisfaction toward managing patients with ADRD. Measures will be completed at baseline (T1), immediately following training (T2), and at the end of the intervention period (T3). This proposal will be the first to study an innovative model of care utilizing PES as specialized hospital caregivers for reducing BPSD in the hospital setting. The investigators' findings will lay the essential groundwork for a multi-site trial of PES-4-BPSD and inform the development of a program that can be easily implemented in other hospitals.

Detailed description

Prior to patient recruitment, a 3 month dementia training program will be implemented on both the intervention and control units. On the intervention unit, training will target the Patient Engagement Specialists (PES) and on the control to the nurse assistants (please refer to NCT# 04179721 for more details on this aim). Following the implementation of the dementia care training, eligible patients will be offered the opportunity to participate in the study. A research coordinator will offer the information and opportunity to participate to the patient's lawful caregiver. The signed consent forms will be stored in secured file cabinets. Once a participant has been enrolled in the study, demographic information will be obtained from the electronic medical records (EMR) and verified by Family Caregiver (FCG), including: age, gender, race/ethnicity, marital status, education, work status, current living situation, medical comorbidities, and reason for admission. A member of the research team will conduct a short interview with the FCG to verify patient background information and obtain baseline (1 month prior to admission) functional status (Barthel Index), dementia severity cognitive (Clinical Dementia Rating Scale)(5 stages of severity: no 0, questionable 0.5, mild 1, moderate 2, and severe 3), and behavioral symptoms using the Neuropsychiatric Inventory-Clinical version NPI-C. A member of the research team will then complete daily NPI-Qs to determine the number of behaviors and symptoms for each patient on a daily basis. The data collector will use a multimodal approach drawing from electronic medical record (EMR) notes and interviews with nursing staff regarding the patient's behavior and treatment over the past 24 hours. Delirium will be assessed daily by the research coordinator using same multimodal approach and during the time of NPI observation. A final EMR chart review will be conducted collecting information such as length of stay, discharge disposition, in-hospital mortality as well as total usage practices for management of BPSD: use of special observation (1:1 or enhanced), restraints, psychoactive medications, psychiatric evaluation. Within 48 hours of discharge, family caregivers will be interviewed regarding satisfaction with care using the Carer Questionnaire Data from the National Audit of Dementia Round 3.

Interventions

We will conduct a non-randomized preliminary efficacy trial, enrolling N=158 patients (79 control and 79 intervention). The primary outcome will be presence of BPSD as measured by a patient's total score on the Neuropsychiatric Inventory-Questionnaire (NPI-Q) during hospitalization. A multi-modal approach (including chart review and HCG questionnaires) will be used to determine the presence and severity of BPSD.

On this unit, the management of patients who display BPSD is performed by nurse assistants, rather than PES. Therefore, in order to test the added layer of PES staff, the nurse assistants on the control unit will receive equivalent dementia care education and training as well as staff support (please refer to NCT# 04179721 for more details on this aim).

Sponsors

National Institute of Nursing Research (NINR)
CollaboratorNIH
Penn State University
CollaboratorOTHER
Northwell Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Nonrandom preliminary efficacy trial comparing 2 groups, intervention and control

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients who have an acute medical admission to either the control unit (Geriatric Care Model) or intervention unit (PES-4-BPSD). * Patients age 65 and above * Documentation of dementia in the medical record (based on the International Classification of Diseases, Ninth and Tenth Revision codes \[ICD-9 and ICD-10\]) * AD8 score of 2 or greater (obtained from the family caregiver \[FCG\])

Exclusion criteria

* Patients who are known to be terminally ill and/or receiving hospice or surgery * Patients with a length of stay of less than 48 hours.

Design outcomes

Primary

MeasureTime frameDescription
Neuropsychiatric Inventory Questionnaire Average Score During Hospital AdmissionParticipant length of stay varies, median of 7 days; will be assessed for 1 year duration of studyThe Neuropsychiatric Inventory Questionnaire (NPI-Q) is a validated tool with 12 behavioral domains for the assessment of neuropsychiatric symptomology designed for completion by caregivers of patients with Alzheimer's Disease and Related Dementias. The tool asks the interviewee to rate each symptom, if present, as mild, moderate, or severe. Total scores range from 0-36 with higher scores indicating greater prominence of dementia symptoms. A Research Coordinator (RC) will utilize a multimodal approach, consisting of daily NPI-Q interviews with Hospital Caregivers and daily reviews of the patient's medical record, to provide a daily assessment of the 12 NPI-Q domains during hospitalization. Upon discharge, the average of each patient's daily NPI-Q total scores will be calculated, and this average will serve as the primary outcome.

Secondary

MeasureTime frameDescription
Length of StayParticipant length of stay varies, median of 7 days; will be assessed for 1 year duration of studyCollected via chart review.
Practices for the Management of BPSDOutcomes vary by participant; will be assessed through duration of study for 1 yearCollected via chart review. Practices include orders placed for special observation (1:1 or enhanced), restraints, psychoactive medications, psychiatric evaluation, as well as adverse events (falls). Orders for constant observation are reported below.
Family Caregiver (FCG) SatisfactionCollected within 48 hours of hospital discharge for the 1-year study durationFCGs will be interviewed by research coordinator with a one-time telephone survey within 48 hours of discharge using the UK National Audit of Dementia Round 3, Caregiver Questionnaire. The survey consists of 10 items assessing perceptions of hospital quality of care provided by hospital staff. Responses of Excellent to the primary question assessed, overall, how would you rate the care received by your loved one during their hospital stay? is reported.

Countries

United States

Participant flow

Participants by arm

ArmCount
The PES-4-BPSD Model
The intervention arm consists of PES and nurse assistants who work on the intervention unit which consists of: I. Cohorting of patients with cognitive impairment AND past or present indication of BPSD, acutely admitted to the medicine or telemetry service, are cohorted on a 10-bed medical unit. II. PES staff: mental health assistants with high school level education, who receive training in de-escalation and crisis prevention techniques and provide direct personal care to psychiatric patients. On the intervention unit, these PES purposefully engage patients with BPSD. III. Staff Support: The PI will hold monthly 20 minute group sessions to reinforce training and discuss challenging patient behaviors; meant to improve the attitude and empathy of HCGs towards patients. IV. Staff Training (please refer to NCT# 04179721 for more details on staff support and training). PES-4-BPSD Model: We will conduct a non-randomized preliminary efficacy trial, enrolling N=158 patients (79 control and 79 intervention). The primary outcome will be presence of BPSD as measured by a patient's total score on the Neuropsychiatric Inventory-Questionnaire (NPI-Q) during hospitalization. A multi-modal approach (including chart review and HCG questionnaires) will be used to determine the presence and severity of BPSD.
79
The Attention Control Condition
The attention control condition will consist of a 40-bed medicine unit, staffed with 39 nurses (1:6 ratio) and 26 nursing assistants (1:8 ratio), that primarily cohorts older patients with geriatric syndromes. The attention control condition: On this unit, the management of patients who display BPSD is performed by nurse assistants, rather than PES. Therefore, in order to test the added layer of PES staff, the nurse assistants on the control unit will receive equivalent dementia care education and training as well as staff support (please refer to NCT# 04179721 for more details on this aim).
79
Total158

Baseline characteristics

CharacteristicThe PES-4-BPSD ModelTotalThe Attention Control Condition
Age, Continuous83.5 years
STANDARD_DEVIATION 8.44
85.2 years
STANDARD_DEVIATION 8.13
86.9 years
STANDARD_DEVIATION 7.48
Baseline Neuropsychiatric inventory questionnaire15.8 score on a scale
STANDARD_DEVIATION 7.49
13.1 score on a scale
STANDARD_DEVIATION 7.51
10.5 score on a scale
STANDARD_DEVIATION 6.6
Charlson Comorbidity Index8.09 score on a scale
STANDARD_DEVIATION 2.66
8.43 score on a scale
STANDARD_DEVIATION 2.67
8.77 score on a scale
STANDARD_DEVIATION 2.65
Clinical Dementia Rating Worksheet final score
0.5 - Questionable Impairment
3 Participants12 Participants9 Participants
Clinical Dementia Rating Worksheet final score
0 - No Impairment
0 Participants0 Participants0 Participants
Clinical Dementia Rating Worksheet final score
1 - Mild Impairment
13 Participants25 Participants12 Participants
Clinical Dementia Rating Worksheet final score
2 - Moderate Impairment
30 Participants51 Participants21 Participants
Clinical Dementia Rating Worksheet final score
3 - Severe Impairment
33 Participants70 Participants37 Participants
Education
Associates degree (e.g., AA, AS)
6 Participants10 Participants4 Participants
Education
Bachelors degree (e.g. BA, BS)
12 Participants19 Participants7 Participants
Education
Doctorate (e.g. PhD, PsyD)
0 Participants4 Participants4 Participants
Education
High school degree or equivalent
34 Participants67 Participants33 Participants
Education
Less than a high school diploma
18 Participants35 Participants17 Participants
Education
Masters degree (e.g. MA, MS)
4 Participants14 Participants10 Participants
Education
Other
5 Participants9 Participants4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants16 Participants10 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
72 Participants138 Participants66 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants4 Participants3 Participants
Marital Status
Divorced
8 Participants18 Participants10 Participants
Marital Status
Married/Domestic Partnership
28 Participants54 Participants26 Participants
Marital Status
Separated
3 Participants4 Participants1 Participants
Marital Status
Single/Never Married
5 Participants7 Participants2 Participants
Marital Status
Widowed
35 Participants75 Participants40 Participants
Previous history of dementia
No
22 Participants31 Participants9 Participants
Previous history of dementia
Yes
57 Participants127 Participants70 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
14 Participants23 Participants9 Participants
Race (NIH/OMB)
Black or African American
27 Participants36 Participants9 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants6 Participants2 Participants
Race (NIH/OMB)
White
34 Participants93 Participants59 Participants
Residence
Assisted-living facility
5 Participants17 Participants12 Participants
Residence
Caregivers home
25 Participants34 Participants9 Participants
Residence
Independent living
1 Participants2 Participants1 Participants
Residence
Nursing home
0 Participants8 Participants8 Participants
Residence
Other
1 Participants1 Participants0 Participants
Residence
Still in own home
47 Participants96 Participants49 Participants
Sex: Female, Male
Female
48 Participants100 Participants52 Participants
Sex: Female, Male
Male
31 Participants58 Participants27 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 792 / 79
other
Total, other adverse events
0 / 790 / 79
serious
Total, serious adverse events
0 / 790 / 79

Outcome results

Primary

Neuropsychiatric Inventory Questionnaire Average Score During Hospital Admission

The Neuropsychiatric Inventory Questionnaire (NPI-Q) is a validated tool with 12 behavioral domains for the assessment of neuropsychiatric symptomology designed for completion by caregivers of patients with Alzheimer's Disease and Related Dementias. The tool asks the interviewee to rate each symptom, if present, as mild, moderate, or severe. Total scores range from 0-36 with higher scores indicating greater prominence of dementia symptoms. A Research Coordinator (RC) will utilize a multimodal approach, consisting of daily NPI-Q interviews with Hospital Caregivers and daily reviews of the patient's medical record, to provide a daily assessment of the 12 NPI-Q domains during hospitalization. Upon discharge, the average of each patient's daily NPI-Q total scores will be calculated, and this average will serve as the primary outcome.

Time frame: Participant length of stay varies, median of 7 days; will be assessed for 1 year duration of study

ArmMeasureValue (MEAN)Dispersion
The PES-4-BPSD ModelNeuropsychiatric Inventory Questionnaire Average Score During Hospital Admission5.36 score on a scaleStandard Deviation 4.64
The Attention Control ConditionNeuropsychiatric Inventory Questionnaire Average Score During Hospital Admission3.87 score on a scaleStandard Deviation 3.37
Secondary

Family Caregiver (FCG) Satisfaction

FCGs will be interviewed by research coordinator with a one-time telephone survey within 48 hours of discharge using the UK National Audit of Dementia Round 3, Caregiver Questionnaire. The survey consists of 10 items assessing perceptions of hospital quality of care provided by hospital staff. Responses of Excellent to the primary question assessed, overall, how would you rate the care received by your loved one during their hospital stay? is reported.

Time frame: Collected within 48 hours of hospital discharge for the 1-year study duration

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
The PES-4-BPSD ModelFamily Caregiver (FCG) Satisfaction34 Participants
The Attention Control ConditionFamily Caregiver (FCG) Satisfaction26 Participants
Secondary

Length of Stay

Collected via chart review.

Time frame: Participant length of stay varies, median of 7 days; will be assessed for 1 year duration of study

ArmMeasureValue (MEDIAN)
The PES-4-BPSD ModelLength of Stay7.00 days
The Attention Control ConditionLength of Stay7.86 days
Secondary

Practices for the Management of BPSD

Collected via chart review. Practices include orders placed for special observation (1:1 or enhanced), restraints, psychoactive medications, psychiatric evaluation, as well as adverse events (falls). Orders for constant observation are reported below.

Time frame: Outcomes vary by participant; will be assessed through duration of study for 1 year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
The PES-4-BPSD ModelPractices for the Management of BPSD17 Participants
The Attention Control ConditionPractices for the Management of BPSD15 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026